Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
BeiGene
BeiGene
University of Nebraska
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Northwestern University
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Canadian Cancer Trials Group
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Mayo Clinic
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Massachusetts General Hospital
University of Washington
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Mayo Clinic
Mayo Clinic
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Progen Pharmaceuticals
Morphotek
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)